Related Experiment Video
Updated: Mar 20, 2026

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
Prediction error, ketamine and psychosis: An updated model.
Philip R Corlett1, Garry D Honey2, Paul C Fletcher3,4
1Department of Psychiatry, Yale University, New Haven, CT, USA.
This study refines the aberrant prediction error model for psychosis, explaining delusions and hallucinations by considering prediction precision and uncertainty. The updated framework offers new insights into the heterogeneity of psychotic disorders.
Area of Science:
- Neuroscience
- Psychiatry
- Computational Neuroscience
Background:
- Delusion formation was previously proposed as aberrant prediction error-driven associative learning.
- Ketamine was identified as a model for this process, with validation in psychosis patients.
Purpose of the Study:
- To review and expand upon the prediction error model of psychosis.
- To explain the heterogeneity of psychotic illness and psychotomimetic drug effects.
- To incorporate precision of predictions and prior expectations into the model.
Main Methods:
- Review of the prediction error minimization principle in brain function.
- Analysis of how prediction errors and their precision can be perturbed.
- Examination of the role of expectation and prediction error uncertainty in psychosis.
Main Results:
- The expanded model explains hallucinations via altered uncertainty balance between expectation and prediction error.
- Negative symptoms may result from unreliable predictions affecting action.
- The model provides a biological basis for belief and perception in psychosis.
Conclusions:
- The refined prediction error model offers novel explanations for psychosis, including hallucinations and negative symptoms.
- The model accounts for the heterogeneity of psychotic disorders and diverse drug effects.
- Future research directions include incorporating more symptoms and refining the biological mapping.
Related Concept Videos
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Psychosis and Antipsychotic Drugs: Overview
Psychosis: Goals of Pharmacotherapy
Pharmacodynamic Models: Additive and Proportional Drug Effect Model
Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model

